Table 5 |
|||||
|
Relative prevalence of various risk factors with increasing age in males and females presented as univariate and adjusted odds ratios and 95% confidence intervals |
|||||
|
Variables |
Age group |
Univariate odds ratios |
Adjusted for body mass index |
Adjusted for waist circumference |
Adjusted for waist hip ratio |
|
|
|||||
|
Males |
|||||
|
|
|||||
|
Smoking |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
5.3 (3.6–7.0) |
-- |
-- |
-- |
|
|
|
|||||
|
30–39 |
16.0 (10.5–21.5) |
-- |
-- |
-- |
|
|
|
|||||
|
Body mass index ≥ 25 kg/m2 |
15–19 |
1.0 |
-- |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
1.6 (0.9–2.7) |
-- |
-- |
-- |
|
|
|
|||||
|
30–39 |
7.1 (4.5–11.2) |
-- |
-- |
-- |
|
|
|
|||||
|
Waist:hip ratio > 0.9 |
15–19 |
1.0 |
1.0 |
-- |
-- |
|
|
|||||
|
20–29 |
4.5 (2.7–7.6) |
-- |
-- |
-- |
|
|
|
|||||
|
30–39 |
21.1 (12.9–34.2) |
-- |
-- |
-- |
|
|
|
|||||
|
Hypertension |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
2.6 (1.2–5.8) |
1.7 (0.7–3.9) |
1.1 (0.4–2.8) |
1.3 (0.5–3.2) |
|
|
|
|||||
|
30–39 |
13.0 (6.9–24.6) |
7.4 (3.7–14.8) |
3.4 (1.5–7.5) |
4.3 (1.9–9.5) |
|
|
|
|||||
|
LDL cholesterol ≥ 130 mg/dl |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
6.4 (3.3–12.2) |
5.9 (3.0–11.5) |
4.7 (2.4–9.4) |
5.4 (2.7–10.9) |
|
|
|
|||||
|
30–39 |
27.4 (15.2–49.6) |
22.2 (11.7–42.0) |
16.7 (8.2–34.1) |
20.1 (9.8–41.3) |
|
|
|
|||||
|
Triglycerides ≥ 150 mg/dl |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
3.7 (1.9–7.1) |
2.7 (1.4–5.4) |
2.4 (1.2–4.8) |
2.6 (1.3–5.1) |
|
|
|
|||||
|
30–39 |
24.2 (13.9–42.1) |
19.9 (10.9–36.1) |
15.8 (8.2–30.8) |
16.8 (8.6–32.6) |
|
|
|
|||||
|
HDL cholesterol < 40 mg/dl |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
2.4 (1.5–3.8) |
2.4 (1.5–3.9) |
1.9 (1.2–3.3) |
1.7 (1.0–2.9) |
|
|
|
|||||
|
30–39 |
15.8 (10.2–24.5) |
15.1 (9.3–24.7) |
12.9 (7.4–22.6) |
10.9 (6.4–18.9) |
|
|
|
|||||
|
Total: HDL cholesterol > 4.5 |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
1.6 (1.4–1.9) |
1.5 (1.3–1.8) |
1.4 (1.1–1.7) |
1.4 (1.2–1.7) |
|
|
|
|||||
|
30–39 |
37.9 (22.5–63.9) |
32.7 (18.6–57.5) |
27.9 (14.8–52.4) |
26.8 (14.3–50.3) |
|
|
|
|||||
|
Diabetes |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
4.0 (0.3–64.5) |
4.2 (0.3–69.9) |
2.6 (1.0–72.3) |
2.4 (0.9–67.0) |
|
|
|
|||||
|
30–39 |
50.7 (6.4–403.4) |
27.8 (3.2–242.7) |
26.2 (1.9–365.8) |
19.9 (1.2–336.1) |
|
|
|
|||||
|
Metabolic syndrome |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
37.7 (4.8–298.2) |
20.7 (2.5–171.7) |
14.3 (1.6–128.4) |
17.3 (2.1–148.5) |
|
|
|
|||||
|
30–39 |
168.5 (22.8–1247.1) |
95.6 (12.3–741.5) |
62.9 (6.4–621.3) |
59.1 (6.2–568.1) |
|
|
|
|||||
|
Females |
|||||
|
|
|||||
|
Smoking |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
1.0 |
-- |
-- |
-- |
|
|
|
|||||
|
30–39 |
6.3 (5.5–7.1) |
-- |
-- |
-- |
|
|
|
|||||
|
Body mass index ≥ 25 kg/m2 |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
0.8 (0.5–1.4) |
-- |
-- |
-- |
|
|
|
|||||
|
30–39 |
11.3 (7.3–11.5) |
-- |
-- |
-- |
|
|
|
|||||
|
Waist:hip ratio > 0.8 |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
3.1 (2.2–4.3) |
-- |
-- |
-- |
|
|
|
|||||
|
30–39 |
17.2 (11.0–26.8) |
-- |
-- |
-- |
|
|
|
|||||
|
Hypertension |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
4.8 (0.9–24.9) |
4.5 (0.9–23.7) |
3.1 (0.6–16.6) |
3.2 (0.6–16.7) |
|
|
|
|||||
|
30–39 |
64.0 (14.9–73.9) |
18.2 (4.1–82.9) |
10.3 (2.0–52.0) |
39.1 (7.9–192.7 |
|
|
|
|||||
|
LDL cholesterol ≥ 130 mg/dl |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
1.8 (0.9–3.6) |
1.8 (0.9–3.5) |
1.6 (0.8–3.2) |
1.9 (0.9–3.7) |
|
|
|
|||||
|
30–39 |
19.5 (11.0–34.4) |
18.2 (9.5–34.8) |
17.2 (8.1–36.7) |
19.5 (9.7–39.2) |
|
|
|
|||||
|
Triglycerides ≥ 150 mg/dl |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
0.9 (0.4–2.0) |
0.9 (0.4–2.0) |
0.8 (0.3–1.8) |
0.8 (0.4–1.9) |
|
|
|
|||||
|
30–39 |
10.0 (5.5–18.2) |
8.5 (4.3–16.6) |
7.0 (3.2–15.1) |
8.2 (4.0–16.8) |
|
|
|
|||||
|
HDL cholesterol < 40 mg/dl |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
0.8 (0.6–1.0) |
0.8 (0.6–1.0) |
0.7 (0.5–0.9) |
0.7 (0.6–1.1) |
|
|
|
|||||
|
30–39 |
14.1 (7.5–26.7) |
11.9 (6.1–23.2) |
10.6 (5.2–21.8) |
15.8 (7.8–32.0) |
|
|
|
|||||
|
Total: HDL cholesterol > 4.5 |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
1.0 (0.9–1.2) |
1.0 (0.8–1.2) |
0.9 (0.8–1.1) |
0.9 (0.8–1.2) |
|
|
|
|||||
|
30–39 |
6.1 (4.5–8.2) |
5.9 (4.3–8.3) |
5.3 (3.7–7.6) |
5.8 (4.1–8.1) |
|
|
|
|||||
|
Diabetes |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|
|||||
|
30–39 |
17.4 (1.9–156.5) |
17.0 (1.3–217.7) |
31.6 (0.6–1605.0) |
22.0 (1.0–474.5) |
|
|
|
|||||
|
Metabolic syndrome |
15–19 |
1.0 |
1.0 |
1.0 |
1.0 |
|
|
|||||
|
20–29 |
5.7 (0.6–55.3) |
5.2 (0.5–51.1) |
2.2 (0.2–23.4) |
3.0 (0.3–31.0) |
|
|
|
|||||
|
30–39 |
146.2 (19.9–1027.9) |
75.1 (9.7–583.9) |
19.7 (2.5–155.3) |
48.8 (6.3–378.9) |
|
|
|
|||||
|
Gupta et al. BMC Cardiovascular Disorders 2009 9:28 doi:10.1186/1471-2261-9-28 |
|||||
